Flores Sally, Kurian Nita, Yohannan Anu, Persaud Christina, Saif Muhammad Wasif
Northwell Health Cancer Institute, Lake Success, NY, USA.
Cancer Med J. 2021 Apr 1;4(1):38-43. Epub 2020 Jun 3.
The battle against cancer is formidable even in normal circumstances and the COVID-19 selectively cancer patients with an increased risk of mortality by three times higher than those without cancer but also forced us to shut down the clinical trials in cancer patients to deal with the present crisis. We discuss here the disruptions on research in cancer with its immediate and delayed consequences and offer some suggestions to modify our practices, strategies and rationalization to help succeed the cancer treatment and research after the crisis is over.
即使在正常情况下，抗癌之战也极为艰巨，而新冠疫情不仅使癌症患者的死亡风险比非癌症患者高出三倍，还迫使我们中断癌症患者的临床试验以应对当前危机。我们在此讨论癌症研究受到的干扰及其直接和延迟影响，并提出一些建议，以调整我们的做法、策略和合理化措施，帮助在危机结束后成功开展癌症治疗和研究。
